Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer

NCT03801876 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT03801876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03801876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 26, 2019
Completion date
November 7, 2036
Enrollment
300 (estimated)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage i esophageal adenocarcinoma ajcc v8, clinical stage i esophageal squamous cell carcinoma ajcc v8, clinical stage i gastroesophageal junction adenocarcinoma ajcc v8, clinical stage ii esophageal adenocarcinoma ajcc v8, clinical stage ii esophageal squamous cell carcinoma ajcc v8, clinical stage ii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iii esophageal adenocarcinoma ajcc v8, clinical stage iii esophageal squamous cell carcinoma ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iva esophageal adenocarcinoma ajcc v8, clinical stage iva esophageal squamous cell carcinoma ajcc v8, clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8, thoracic esophagus squamous cell carcinoma